4728.TWO Sunmax Biotechnology Co Ltd

Healthcare Biotechnology Taiwan OTC Exchange
390.50 TWD
Close of Nov 6, 2026
350.00 416.00
Market cap
TWD 21.3B
P/E
26.2x
P/B
14.81x
ROE
64.9%
Dividend yield
2.97%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 4728.TWO undervalued?

Graham number

The Graham number of Sunmax Biotechnology Co Ltd cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Sunmax Biotechnology Co Ltd fundamental analysis

No fundamental analysis for Sunmax Biotechnology Co Ltd yet.

Sunmax Biotechnology Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Sunmax Biotechnology Co Ltd

Sunmax Biotechnology Co., Ltd., a biomedical company, engages in the research, development, manufacturing, and sales of biomedical-grade collagen and related products in Taiwan, Mainland China, and internationally. It offers collagen dermal filler sets, such as Sunmax Deusaderm VITAL and Sunmax Deusaderm LIDO injectable collagen gel with lidocaine. The company was founded in 2001 and is based in Tainan City, Taiwan.

Full company profile